Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	76.28	38.97	22.11
Graham Fair Price	-81.88	4.45	24.54
PEG	5201.37	2.20	0.04
Price/Book	35.27	10.70	7.91
Price/Cash Flow	1521.23	308.53	19.03
Prices/Earnings	2591.08	-228.35	8.49
Price/Sales	43.75	3.42	2.38
Price/FCF	1521.23	308.53	19.03
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.58	0.24	0.24
Operating Margin	-37.14	0.07	0.11
ROA	-95.89	< 0.005	0.03
ROE	0.23	-0.01	-94.97
ROIC	0.07	-0.04	-37.49
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	-0.05	-53.45
Dividends QOQ	< 0.005	0.16	2430.50
EBIT QOQ	-0.06	-0.53	-726.81
EPS QOQ	2.05	-1.04	-49.24
FCF QOQ	1.02	-0.93	-8.23
Revenue QOQ	0.09	-0.25	170.16
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	95.15	127.31	33.81
Days Sales Outstanding (DSO)	23.98	25.19	5.05
Inventory Turnover	0.95	0.71	-25.26
Debt/Capitalization	0.78	0.82	5.10
Quick Ratio	0.53	0.44	-15.71
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	10.72	8.66	-19.17
Cash	7.93	7.14	-9.96
Capex	-3.01	-1.00	66.63
Free Cash Flow	4.45	0.30	-93.26
Revenue	35.66	27.13	-23.94
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.41	1.35	-4.50
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.14	10.62	73.04
Naive Interpretation	Member

06 - Financial Health · Weak

Rating